|
|
|
Orphan Drug Stops Priapism, Reverses Penis Damage in Mice By Daniel J. DeNoon WebMD Health News Nov. 4, 2009 -- Men suffering penis pain and damage from erections lasting longer than four hours may benefit from an orphan drug...
Survey Shows Patients Want Straight Talk About Chances of Survival By Charlene Laino WebMD Health News Nov. 4, 2009 (Chicago) -- Ninety-five percent said they wanted their doctor to be honest about their chances of a cure and...
CHICAGO - A patient's socioeconomic status (income, martial status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new study from Henry...
Fresh data on prostatectomy are presented in the report 'Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation.' According to a study...
A report, 'Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience,' is newly published data in Bju...
November 04, 2009 | about: American Medical Systems Holdings, Inc., Q3 2009 Earnings Call Executives Anthony Bihl - Thank you for joining us today on this call to discuss American Medical Systems’ third quarter results. Any...
American Medical Systems Earnings Conference Call (Q3 2009) Scheduled to start Wed, Nov 4, 2009, 5:00 pm Eastern -- this event is ongoing now-- After the event has finished, the audio will be available from this page until Fri,...
MILWAUKEE - The American Cancer Society is changing its recommendations for screening. Back in 1993 he began having an annual PSA (Prostate Specific Antigen) test. The PSA is a simple blood test for prostate cancer. In 2005,...
When it comes to health care, we men are like ostriches. Yet it’s obviously important that men of all ages become more proactive about their health. As a result, they rapidly drive up blood sugar levels, which contributes to...
Mark Henderson, Science Editor A nanotechnology therapy that targets cancer with a “stealth smart bomb” is to begin patient trials next year in the first clinical test of a pioneering approach to medicine, The Times has learnt....
